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Infants’ exposure (Nf  ) to Cronobacter sakazakii via the consumption of infant-rich-in-
polyphenols cocoa-milk-based beverages (CCX-M) treated with high-intensity pulsed 
electric fields (PEF) was evaluated. Monte Carlo simulation enabled the prediction 
of the variability in C. sakazakii load in beverages at the time of consumption to be 
estimated. Different scenarios (initial contamination levels; PEF treatment conditions; 
and time-temperature combinations of CCX-M beverages storage after treatment) were 
simulated. Cocoa addition and PEF treatment resulted in the most influential input 
factors to control bacterial final load. Cronobacter spp. exposure risk was reduced by 
a maximum of 100 times at 95% of iterations due to addition of cocoa at 5 g/100 mL, 
corresponding to scenario 3 (PEF: 15 kV/cm–3,000 µs; storage 120 h at 8 °C). Moreover, 
the probability of illness for a healthy population was reduced from 2.15 × 10-8, 
in the baseline scenario, to 4.78 × 10-10 due to cocoa addition and application of 
15 kV/cm–3,000 µs PEF treatment. 
Keywords: Cronobacter sakazakii; exposure assessment; infant beverages rich-in-polyphenols cocoa; pulsed 
electric field (PEF)
Introduction
Infant liquid milk-based beverages fre-
quently come from powdered infant for-
mula milk (PIFM) which can be considered 
as risk products due to potential con-
tamination by Cronobacter sakazakii (Lai 
2001; Bowen and Braden 2006; FAO/
WHO 2008). According to the preliminary 
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assessment of the risks associated with C. 
sakazakii in PIFM conducted by FAO/
WHO (2006), additional control measures 
after reconstitution of PIFM, such as the 
addition of an inhibitor or biopreservative 
agent to reconstituted PIFM (RPIFM), or 
the use of bactericidal/pasteurisation addi-
tional processes are required to obtain 
microbiologically safe RPIFM. Alternative 
treatments to those that use heat aim to 
ensure not only the microbiological safety 
of RPIFM but also the nutritional quality 
of this product, which could be affected by 
elevated temperatures (Barbosa-Cánovas 
and Bermudez-Aguirre 2010). Recent 
studies have been conducted on the pos-
sible impact of new non-thermal technolo-
gies on C. sakazakii inactivation. These 
include high hydrostatic pressure (HHP) 
(González et al. 2006; Pina-Pérez et al. 
2007a; Arroyo et al. 2011a), pulsed elec-
tric field technology (PEF) (Pina-Pérez 
et al. 2007b; Arroyo et al. 2010a,b), ultra-
sound (Adekunte et al. 2010; Arroyo et al. 
2011b) and natural antimicrobials (Nair, 
Joy and Venkitanarayanan 2004; Jang and 
Rhee 2008; Amalaradjou, Hoagland and 
Venkitanarayanan 2009). PEF technol-
ogy is suggested as a possible non-ther-
mal alternative process to control this 
microorganism in industrial and hospital 
settings (Pina-Pérez et al. 2007b, 2009a; 
Arroyo et al. 2010a,b). In recent years, the 
use of substances of a functional nature 
that act as ingredients in food formulation 
and, in turn, may also prevent the devel-
opment of hazardous microorganisms 
(Marco et al. 2011) is gaining relevance. 
The hurdle technology concept, based on 
the successive or simultaneous application 
of barriers to microbial growth, is being 
used, increasing the intensity of physical 
preservation processes. In this respect, the 
availability and recent interest in certain 
minimally processed cocoa derivatives/
concentrates and flavonoid-rich extracts, 
are encouraging the development of a 
variety of products with functional and 
antimicrobial properties. Polyphenols have 
been described to have significant antimi-
crobial effects against Gram positive and 
Gram negative bacteria (Busta and Peck 
1968; Pina-Pérez et al. 2009b; Pina-Pérez, 
Rodrigo and Martinez 2011). Recently, 
Kim et al. (2009) obtained a reduction in 
C. sakazakii to undetectable levels due 
to muscadine seed extracts cell exposure 
(30–60 min). Pina-Pérez, Martínez López 
and Rodrigo (2013) in a previous study 
determined that 5 g/100 mL of cocoa 
added to milk formula, at a specified step 
in the refrigeration period (post-treat-
ment), reduced C. sakazakii, achieving the 
maximum inactivation level obtained up 
to date due to PEF application. 
To produce novel tasty and safe prod-
ucts for children, exposure risk assessment 
studies should be carried out at various 
stages from production to consumption, 
with a view to reducing the number of 
microorganisms at particular steps in the 
production chain. For quantitative risk 
assessment, a stochastic approach using 
frequency or probability distributions for 
model inputs is recommended, to take 
account of uncertainties and variabilities 
(Lammerding and Fazil 2000; Pouillot and 
Delignette-Muller 2010). 
The overall objective of this study was 
to assess the exposure of children consum-
ing infant rich-in-polyphenols-cocoa milk 
based (CCX-M) beverages to C. sakazakii. 
Inactivation results from PEF application 
under different conditions followed by the 
storage of treated beverages were mathe-
matically simulated to estimate the final 
number of microorganisms at the time 
of consumption. The specific objectives 
of the present study were to estimate the 
exposure values at the time of consump-
tion by healthy and immunodepressed 
children to generate data that could be 
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used in future C. sakazakii risk assess-
ments associated with novel products pro-
cessed by hurdle technologies. By means 
of the stochastic methodology of analysis, 
the present work considered the research 
needs in the field of the validation of the 
effectiveness of novel technologies. 
Materials and Methods
Bacterial strain and growth medium
The Spanish Type Culture Collection 
(CECT 858) provided the pure culture of 
C. sakazakii (equivalent to strain 29544 
ATCC) in a lyophilised state. Obtaining 
stock culture was carried out according 
to Pina-Pérez et al. (2007a, 2009a). Prior 
to use, cells in the stationary phase were 
stocked and stored at -80 °C. The final 
concentration in the stocked vials was 109 
Colony Forming Units (cfu) per mL. 
Pulsed Electric Field equipment
An OSU-4D bench-scale continuous PEF 
system (Columbus, OH 43210-1007, USA) 
was used to inactivate Cronobacter spp. 
suspended in different CCX-M beverages. 
The bath temperature was set at 4 °C. The 
pulse, voltage and intensity of treatment 
were recorded by a digital oscilloscope 
(Tektronic TDS 210, Tektronic, OR). The 
flow was set at 30 mL/min using a gear pump 
(Cole-Parmer 75210-25, Cole – Instruments 
Parmer, IL). The square-wave bipolar 
pulse duration was 2.5 µs. The treatment 
times ranged between 60 and 3,000 µs, and 
the electric field intensity was 15, 25, and 
35 kV/cm (see Table 1). The final tempera-
ture remained below 25±3 °C for all treat-
ment conditions. 
Beverage preparation and inoculation
Beverages were prepared as a mixture 
of CCX (12% minimum polyphenols 
concentration) added to RPIFM (10 g 
Table 1. Pulsed electric field treatment conditions 
[E, electric field strength (kV/cm); t, treatment 
time, (µs)] applied to Cronobacter sakazakii control 
in cocoa-milk based beverages (CCX-M beverages)
E (kV/cm) t (µs)
15                       60
240
500
700
1,660
3,000
25 60
180
240
500
860
1,660
35 60
240
360
420
500
700
PIFM/100 mL) (Nutriben Natal®, Alter 
Farmacia, SA) at 1 g/100 mL (CCX-M-
1%) at 2.5 g/100 mL (CCX-M-2.5%), and 
5 g/100 mL (CCX-M-5%). A control bev-
erage (10 g PIFM/100 mL) was processed 
without cocoa addition (CCX-M-0%) and 
was prepared according to the manufac-
turer’ instructions. Beverages were inocu-
lated to a final concentration of 108 cfu 
per mL. 
The beverages were treated under 
the same PEF conditions, electric field-
strength (E, kV/cm) – treatment time (t, 
µs) combinations. After PEF treatment, 
CCX-M beverages were kept under dif-
ferent storage conditions: 8 °C and 25 °C 
(stirring conditions at 250 rpm) with a 
total storage time from 24 h to 120 h.
Viable counts
Control and PEF treated samples were 
collected and serially diluted in 0.1% ster-
ile peptone water, plated on TSA agar, and 
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incubated at 37 °C 24 h. The experiments 
were performed by triplicate.
Exposure assessment model
The potential exposure to C. sakazakii by 
consumption of a single serving (100 mL) 
of CCX-M infant beverages was estimated. 
For this, an exposure assessment model 
was built to describe the distribution of 
the final C. sakazakii load probabilities 
after different PEF inactivation treat-
ments and storage conditions, covering 
the process pathway from PEF processing 
of CCX-M infant beverage to consump-
tion (Figure 1). 
A summary of the input variable dis-
tributions, models, and data sources used 
to simulate the C. sakazakii final load in 
different CCX-M beverages is presented 
in Table 2. Inputs and assumptions of 
the global exposure model are defined 
below: 
(1) It is assumed a product serving size 
was 10 g PIFM per 100 mL of novel 
CCX-M infant beverage. 
(2) The initial concentration (N0) of 
Cronobacter sakazakii in beverages 
was based on data of contamina-
tion levels in PIFM reported by 
FAO/WHO (2008) and estimated 
from a thousand samples. It was 
defined by a cumulative distribu-
tion function as follows: cumulative 
(-5.24;-2.79; {-3.30;-3.70;-4.20; 
-4.70;-5.24}; {0.21;0.43;0.65;0.91; 
0.99}) log(cfu/g). 
(3) PEF inactivation and growth during 
storage were fitted to mathematical 
models. 
(4) To predict the microbial reduction 
level due to each PEF treatment, 
the Weibull model was fitted to the 
experimental data according to the 
following equation: 
N0  Cronobacter spp. initial concentration  
Pulsed electric fields treatment (PEFs) (15, 25, 35) kV/cm) 
Storage growth description (Nf PEF+STORAGE) 
Post-processing storage (8 ºC, 24-120 h)  
Number of ingested Cronobacter spp. per contaminated service (cfu/100ml) 
Inactivation kinetics fit (Nf PEF) 
Rich in polyphenols cocoa supplementation (0, 1, 2.5 and 5 % (w/v)) 
Figure 1. Framework of the Cronobacter sakazakii exposure assessment process by con-
sumption of PEF treated and stored rich-in-polyphenols-cocoa milk based infant beverages 
(CCX-M). 
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   
=−     0 ,
n
PEFNf tLog
N b
 
(Equation 1)
 where log [NfPEF/N0] versus time t is 
the decimal logarithm of S; where S 
is the fraction of survivors [NfPEF/N0] 
at treatment time (t), b and n are the 
scale and shape factors, respectively. 
To ascertain the goodness of fit provid-
ed by the model, the following coeffi-
cients were used: corrected regression 
coefficient (R2-corrected) and the 
root mean square error (RMSE) 
(Statgraphics Centurion XV, version 
15.1.03, Statpoint Inc., 2005, USA).
(5) After treatment, cells were stored at 
different temperatures (8 and 25 °C) 
and the microbial increase during 
the storage period was measured. 
According to Carrasco et al. (2010), 
the equation of exponential growth 
(equation 2) was used to calculate 
the concentration of cells during 
the storage period. The final load 
after PEF application was used as 
the dynamic initial load in the storage 
stage mathe matical simulation. 
 µ+ = + ⋅max ,PEF STORAGE PEFLogNf LogNf t  
 (Equation 2)
 where NfPEF+STORAGE is the con-
centration of cells (cfu/mL) at the 
end of the stage considered, NfPEF 
is the concentration of cells (cfu/
mL) at the beginning of the storage 
stage, µmax is the maximum growth 
rate [log10 (cfu/mL)/h] and, t is the 
duration of the storage stage (h). 
Maximum specific growth rate [µmax, 
log10 (cfu/mL)/h] distribution func-
tions of obtained values at 8 and 
25 °C are presented in Table 2. 
(6) The time storage period (ti) studied 
ranged from 24 h to 120 h (up to 5 
days). Va
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“What if” scenarios
In the present study, the baseline model for 
each beverage was considered as the refrig-
erated storage of contaminated CCX-M 
beverages, at conditions of 8 °C – 24 h 
(FAO/WHO 2006), without previous PEF 
treatment. Different models called “What 
if” scenarios were run based on the modifi-
cation of different initial conditions (initial 
load [N0], PEF treatment, storage tempera-
ture, storage time). These scenarios repre-
sent the individual effect of each factor.
Five scenarios were considered as fol-
lows, for each beverage, in order to cover 
different possibilities regarding CCX-M 
consumption at home, with the aim of 
quantifying control measures that impact 
on CCX-M food safety: 
a) Scenario 1: What if “CCX-M bever-
ages were treated by the most effec-
tive PEF treatment according to 
Pina-Pérez et al. (2009a), 15 kV/cm– 
3,000 µs, before refrigerated storage 
8 °C, 24 h?” 
 The number of C. sakazakii 
counts after PEF (NfPEF, cfu/mL) 
and after the complete process 
(NfPEF+STORAGE, cfu/mL) were the 
outputs of the exposure model.  
(7) Risk characterisation. The probability 
of illness by consumption of con-
taminated CCX-M infant beverages 
was also obtained as an output of 
the exposure dose-response model 
proposed by Teunis and Havelaar 
(2000). Two populations were con-
sidered: immunodepressed and non-
immunodepressed populations. 
Figure 2 shows the flow diagram of the sto-
chastic model. The model was constructed 
using the software Risk Analysis add-in 
for Microsoft Excel, @ Risk 4.5 (Palisade 
Corporation, Newfield, NY, USA). Monte 
Carlo simulation was run (100,000 itera-
tions) by random sampling in distributions 
describing the variability of the input vari-
ables, using the Latin Hypercube sampling 
method. 
N0
NfPEF
NfPEF+STORAGE
I
n
b
t
T
µ
max
ti
Figure 2. Flow diagram of the stochastic model used to evaluate the Cronobacter sakazakii 
contamination of infant milk beverages not supplemented (CCX-M-0%)/supplemented with 
rich-in-polyphenols-cocoa at different concentration (1, 2.5, and 5% [w/v]) after PEF and 
storage. Circles are used for random variables and squares indicate fixed parameters.
82     IRISH JOURNAL OF AGRICULTURAL AND FOOD RESEARCH, VOL. 53, NO. 1, 2014
b) Scenario 2: What if “treatment inten-
sity was increased from 15 kV/cm– 
3,000 µs to 35 kV/cm–700 µs?” 
Taking into account that the effec-
tiveness of PEF depends on electric 
field strength and treatment time 
(Pina-Pérez et al. 2007b, 2009a; 
Arroyo et al. 2010a,b), the distribu-
tion function that defines the level 
of C. sakazakii reduction due to PEF 
treatment was estimated by Monte 
Carlo simulation based on an inacti-
vation model. 
c) Scenario 3: What if “the storage time 
of PEF treated (15 kV/cm–3,000 µs) 
beverages was prolonged from 24 h 
to 120 h at 8 °C?” 
d) Scenario 4: What if “storage tem-
perature of PEF treated (15 kV/
cm–3,000 µs) CCX-M beverages was 
increased from 8 °C (maximum limit 
specified by CAC 2008) to 25 °C?” It 
was assumed that temperature follows 
a Normal distribution (25±2.5 °C). 
e) Scenario 5: What if “the initial con-
tamination level (N0) exceeded con-
siderably the likely FAO/WHO (2008 
levels)? from 10-3 cfu/g to 10 cfu/g 
defined by a lognormal distribution 
[1 log cfu/g; 0.1]. 
Results and Discussion
Inactivation kinetics results
The levels of inactivation were influenced 
both by the PEF treatment (electric field 
strength [E] and treatment time [t]) and 
CCX addition. The effect of process 
parameters on C. sakazakii inactivation 
has been described previously by Pina-
Pérez et al. (2007b, 2009a) and Arroyo 
et al. (2010a,b). The higher the cocoa 
concentration added to infant beverage, 
the higher the PEF inactivation effect, 
according to Pina-Pérez et al. (2013). The 
maximum inactivation level achieved in 
CCX-M-0% was 1.30 log10 cycles cor-
responding to 35 kV/cm–700 µs PEF 
treatment. At the same conditions, the 
maximum reduction level achieved in 
CCX supplemented beverages (5, 2.5 
or 1 g/100 mL) was up to 2.10±0.12, 
1.70±0.08, or 1.55±0.03 log10 cycles, 
respectively (Figure 3). The PEF survival 
curves were fitted to the Weibull model 
and kinetic parameters (scale and shape) 
were obtained. No significant differences 
(P>0.05) were observed between the 
shape parameter values in different bev-
erages and at the PEF treatment con-
ditions studied, so a simplified model 
substituting the n parameter by an aver-
age value (n=0.561) was obtained. Scale 
parameter values and the goodness of the 
simplified fit are presented in Table 3. 
After PEF treatments, different bever-
ages were stored at 8 °C from 24 to 120 h 
and C. sakazakii propagation was evaluat-
ed during the storage time. Cocoa addition 
at 5 g/100 mL (w/v) increased post-treat-
ment inactivation rates (P<0.05) (to unde-
tectable limits) after all PEF treatment 
conditions studied (15 kV/cm–3,000 µs; 
8 °C, 120 h). According to Pina-Pérez et al. 
(2009a), 15 kV/cm–3,000 µs was the most 
effective treatment to control propaga-
tion of C. sakazakii cells at refrigeration 
temperatures. In this sense, and accord-
ing to the present results, cocoa addition 
with refrigerated storage represents an 
additional barrier to proliferation of C. 
sakazakii post-PEF treatment.
Exposure assessment results
The outputs within the baseline model and 
“what if” scenarios, for control CCX-M 
and supplemented CCX-M milk beverages, 
are presented in Table 4. Regarding the 
PEF effect on CCX-M-0%, a significant 
contribution to the reduction in the popu-
lation of C. sakazakii can be attributed to 
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700 µs (scenario 1 vs. scenario 2), when 
these treatments were followed by a 24 h, 
8 °C storage period. On the other hand, 
cocoa addition enhanced PEF effectiveness 
against C. sakazakii (scenarios 1, 2, and 
15 kV/cm–3,000 µs PEF application (base-
line vs. scenario 1). However, no significant 
decrease in final load values (cfu per serving) 
was observed due to PEF intensity increase 
from 15 kV/cm–3,000 µs to 35 kV/cm– 
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Figure 3. Pulsed electric field (PEF) survival curves (a) 15 kV/cm–3,000 µs, (b) 25 kV/
cm–1,660 µs, (c) 35 kV/cm–700 µs, for Cronobacter sakazakii in infant milk beverages 
not supplemented (CCX-M-0%)/ supplemented with rich-in-polyphenols-cocoa at different 
concentrations (1, 2.5 and 5% [w/v]). 
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3) and therefore, represents a significant 
control measure for reducing the risk of 
exposure to this pathogen (e.g. scenario 
3; probability of illness in healthy popula-
tion equals 7.35×10-6 in CCX-M-0% which 
is reduced to 1.56×10-8 in CCX-M-5%). 
Considering the assumptions related to 
scenario 1, cocoa addition at 5 g/100 mL 
controlled C. sakazakii cells by increasing 
PEF effectiveness by ~1 log10 cycle at the 
95% of iterations. The probability of illness 
for non-immunodepressed populations, 
was reduced by 10–100 times in beverage 
supplemented with cocoa (e.g. scenario 
2–3, respectively), and also significantly 
reduced for immunodepressed populations 
due to cocoa addition (e.g. scenario 4).
The most important cocoa intervention 
for C. sakazakii control occurred when 
storage temperature remained at 8 °C 
and storage time increased from 24 to 
120 h (scenario 3). Under the conditions 
corresponding to scenario 3, the final 
load increased from baseline 1.17×10-6 
up to 3.0×10-3 cfu per serving (95% of 
iterations) in infant milk beverage not 
supplemented with cocoa. In this case, 
the cocoa addition seems to act syner-
gistically with refrigerated storage after 
PEF (Pina-Pérez et al. 2013), reducing the 
C. sakazakii cell counts to 8.87×10-5 cfu 
per serving at 95% of the iterations. The 
increase in sensitisation of treated cells 
due to the exposure to additional stress 
conditions post-treatment is well known 
(Pol et al. 2001; Rodrigo et al. 2007; Pina-
Pérez et al. 2009b, 2012). In this sense, 
the addition of this natural antimicrobial 
ingredient in the formulation of beverages 
could reduce the exposure risk even more 
during shelf life. 
In spite of PEF treatment, storage at 
room temperature (25 °C) (scenario 4) 
increased C. sakazakii cfu per serving up 
to 104 at 95% of iterations, with respect 
to the baseline (1.17×10-6 cfu per serv-
ing). This temperature could occur if a 
beverage remains outside the fridge prior 
to or during feeding at home (Joosten 
and Lardeau 2004). Consequently, the 
increase in storage temperature resulted 
in an enhanced exposure risk, increasing 
the probability of illness for healthy popu-
lations from 2.45×10-8 (scenario 1) to ≈1 
Table 3. Simplified Weibull model kinetic parameter (a) values and goodness of fit (R2-corrected and 
RMSE) for Cronobacter sakazakii inactivation in infant milk control beverage (CCX-M-0%) and infant rich-
in-polyphenols cocoa-milk based beverages (CCX-M-1%; CCX-M-2.5%; CCX-M-5%), with a constant shape 
parameter (naverage = 0.561)
E1  Beverage  a2  R2 corrected  RMSE
15 kV/cm CCX-M-0%  0.012  0.945  0.038
 CCX-M-1%  0.013  0.919  0.107
 CCX-M-2.5%  0.015  0.903  0.107
 CCX-M-5%  0.018  0.919  0.100
25 kV/cm CCX-M-0%  0.011  0.965  0.040
 CCX-M-1%  0.011  0.969  0.043
 CCX-M-2.5%  0.013  0.963  0.042
 CCX-M-5%  0.014  0.972  0.036
35 kV/cm CCX-M-0%  0.027  0.866  0.121
 CCX-M-1%  0.039  0.895  0.102
 CCX-M-2.5%  0.042  0.974  0.123
 CCX-M-5%  0.051  0.905  0.123
1E = electric field intensity (kV/cm). 
2a = scale parameter of Weibull model.
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(scenario 4) at 95% of iterations, after 
consumption of un-supplemented bever-
age. Cocoa intervention at 5 g/100 mL 
significantly reduced the probability of ill-
ness for a healthy population (Prob1=0.13, 
95% of iterations) (scenario 4). The 
increase in storage temperature after PEF 
of CCX-M-0%, led to a final ingested 
dose of 12,900 cfu (per contaminated 
serving) at 95% of iterations. This ingest-
ed dose is considerably above the value 
of 1000 cfu considered as infective for 
this microorganism (Iversen and Forsythe 
2003). However, cocoa supplementation 
at 5 g/100 mL provided a final C. sakazakii 
count per serving around 10 times below 
the concentration of concern. 
The initial load variation had a sig-
nificant effect on the final C. sakazakii 
numbers and probability of illness values, 
according to simulation results obtained 
for scenario 5. In this sense, different 
authors have pointed out the effective-
ness of controlling this parameter in risk 
prevention (Ferrer et al. 2007; Pina-Pérez 
et al. 2010). The addition of cocoa at 5% 
(w/v) to infant beverage treated by PEF 
controls C. sakazakii levels below ~1 cfu 
per serving (95% of iterations), even with 
a high initial contamination level defined 
by Normal distribution N(1; 0.1), and 
under limit storage conditions (8 °C, 24 h) 
by FAO/OMS (2008). 
For all scenarios studied, cocoa addition 
reduced the final C. sakazakii load from 
0.6 to 1.70 log10 cycles, at 95% of itera-
tions, depending on the scenario consid-
ered, and reduced the probability of illness 
for the two populations considered. 
The simulation of the different sce-
narios indicates that the highest poten-
tial probability of illness could occur by 
the combination of different parameters 
under inappropriate conditions: (i) high 
initial load, (ii) high temperatures of 
infant beverage storage, and (iii) long 
storage times. In order to allocate the 
influence of each input on the output 
variation value (Pouillot and  Delignette-
Muller 2010), a sensitivity analysis was 
carried out. Table 5 shows the correlation 
coefficient (r) resulting from the analysis 
for each simulated scenario. Taking into 
account these results, N0 (log10 (cfu/mL)) 
and storage temperature are the variables 
that exert the greatest influence on the 
final Nf values, when no treatment has 
been applied (baseline scenario), accord-
ing to previous studies (Kandhai et al. 
2006; Beuchat et al. 2009). However, it 
can be shown that in scenarios with PEF 
application, PEF intensity (e.g. scenario 1 
[r=-0.85] and 2 [r=-0.70]), cocoa addition 
and storage temperature (e.g. scenario 4 
[r=0.70]), became significant determinants 
of the final load. Particularly, for scen-
ario 3 (PEF=15 kV/cm–3,000 µs; storage= 
8 °C, 120 h), when reconstituted PIFM 
was processed by PEF with storage at 
8 °C for 120 h, cocoa addition represented 
Table 5. Correlation coefficients from the sensitivity analysis performed at different Cronobacter spp.  
exposure assessment “what if” scenarios
Scenario  
 
 Correlation coefficients
Cocoa addition N0  PEF treatment Storage temperature Storage time
Baseline  0.05  0.97 –  0.68  0.52
Scenario 1 -0.75  0.40 -0.85  -0.45  -0.10
Scenario 2 -0.85  0.41 -0.70  0.11  0.05
Scenario 3 -0.98  0.50 -0.65  0.13  0.18
Scenario 4 -0.75  0.70 -0.18  0.70  0.58
Scenario 5 -0.10  0.97 -0.60  0.12  0.06
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the most influential parameter controlling 
bacterial load (r=-0.98), which points to 
the potential of cocoa to control C. saka-
zakii proliferation specifically during 
storage of minimally processed products, 
even after extensive storage periods. On 
the other hand, for scenario 4 (PEF= 
15 kV/cm–3,000 µs; storage=25 °C, 24 h) 
temperature (r=0.70) became one of the 
most influential parameters on the output 
value, due to its considerable increase with 
respect to the baseline model (from 8 to 
25 °C). In this scenario that corresponds 
to storage temperature abuse, cocoa addi-
tion became a significant parameter con-
tributing to C. sakazakii control. This 
result points to the relevance of tempera-
ture control and adopting CAC (2008) 
measures and recommendations in terms 
of handling, reconstitution and storage 
(Rosset, Noel and Morelli 2007) of prod-
ucts from infant powdered milk. When the 
initial load increased considerably (sce-
nario 5) (N0=1 log10 cfu/g; PEF=15 kV/cm– 
3,000 µs; storage=8 °C, 24 h), N0 and PEF 
treatment were the two most influential 
parameters (r=0.97 and -0.80, respective-
ly) defining the C. sakazakii final load at 
the time of consumption. These results 
could be explained by the influence of 
N0 on final C. sakazakii exposure levels, 
and that at the most likely C. sakazakii 
contamination levels (EFSA 2007) con-
tamination of PIFM could be reduced 
effectively by PEF technology. 
Conclusion
The present study provides a preliminary 
approach to the estimation of the prob-
ability of C. sakazakii exposure after non-
thermal processing of infant milk beverage 
supplemented/not supplemented with 
rich-in-polyphenols-cocoa. Knowledge 
concerning C. sakazakii risk exposure by 
consumption of novel PEF treated milk is 
required to determine the applicability of 
this technology, mainly at industrial level 
to manufacture beverages that add powder 
formula as an ingredient in formulation. 
In this regard, the present research is the 
first step in estimating the effectiveness 
of a hurdle combination (PEF and cocoa 
ingredient) technology and assessing the 
effect of inadequate handling conditions 
(high N0 level, prolonged storage time 
and high storage temperatures [>8 °C]) 
which could occur, and therefore provides 
useful information from a risk prevention 
viewpoint. 
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